{
    "nctId": "NCT05365243",
    "briefTitle": "A Pilot Study to Evaluate the Use of the AMMA Portable Scalp Cooling System From Cooler Heads",
    "officialTitle": "A Pilot Study to Evaluate the Use of the AMMA Portable Scalp Cooling System",
    "overallStatus": "WITHDRAWN",
    "conditions": "Alopecia, Chemotherapy-induced Alopecia, Hair Loss, Breast Cancer, Gynecologic Cancer",
    "studyType": "INTERVENTIONAL",
    "phase": "NA",
    "allocation": "NA",
    "primaryPurpose": "SUPPORTIVE_CARE",
    "enrollmentCount": 0,
    "primaryOutcomeMeasure": "Compliance with AMMA use",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* Female age 21 years or older at the time of signing informed consent.\n* Documented pathologic diagnosis of invasive breast or gynecologic cancer, any stage, requiring treatment with a taxane-containing chemotherapy regimen\n* Planned start of treatment with taxane-based chemotherapy in the adjuvant, neoadjuvant or advanced setting\n* Plan to complete chemotherapy within 6 months of treatment start\n* If received prior chemotherapy causing hair loss, \\>/= 2 years since last chemotherapy dose and complete recovery of hair\n* ECOG performance status 0-1\n* Willing and able to sign informed consent for study procedures\n* Willing and able to participate in all study procedures\n\nExclusion Criteria:\n\n* Plan to use chemotherapy regimen other than that listed in inclusion criteria, including any anthracycline-based regimen\n* Plan to initiate bone marrow ablation chemotherapy\n* History of or plan to initiate whole or partial brain or skull irradiation\n* Hormone therapy concurrent with current chemotherapy regimen\n* Existing or suspected scalp metastases\n* History of concomitant diagnosis of: autoimmune disease affecting hair; cryoglobulinemia; untreated iron deficiency with or without anemia; cold agglutination disease; post-traumatic cold dystrophy; untreated or poorly controlled hyper- or hypothyroidism\n* Female pattern baldness\n* History of persistent chemotherapy-induced alopecia from prior chemotherapy\n* Concomitant exposure to investigational agents, drugs, devices or procedures that cause hair loss\n* Concomitant other solid tumor or hematologic malignancy in addition to the current diagnosis",
    "sex": "FEMALE",
    "minimumAge": "21 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}